Clinical trial
Efficacy of Hydroxyzine Versus Treatment as Usual for Panic Disorder: An Eight-Week, Open Label, Pilot, Randomized Controlled Trial.
NCT05737511 is registered in ClinicalTrials.gov with Sultan Qaboos University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Hydroxyzine Versus Treatment as Usual for Panic Disorder: An Eight-Week, Open Label, Pilot, Randomized Controlled Trial.
- Lead sponsor
- Sultan Qaboos University
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- December 30, 2023
- Completion date
- December 30, 2026
- Enrollment
- 80 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.